Chirogate International Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 3 name spellings.
1
Ending by 2030
Apr 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 25, 2027The maintenance fee for Processes and intermediates for the preparations of isomer free prostaglandins (US 9,115,109) comes due Feb 25, 2027. Unpaid by Aug 25, 2027, it lapses early.
- 1 fee due Apr 29, 2027The maintenance fee for Process for the preparation of Lubiprostone and intermediates thereof (US 10,457,623) comes due Apr 29, 2027. Unpaid by Oct 29, 2027, it lapses early.
- 2 fees due Jul 30, 2027
- 2 fees due Sep 3, 2027
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,546,114 | Processes for the preparation of optically active cyclopentenones and cyclopentenones prepared therefrom In force · From the USPTO record | In force | From the USPTO record | |
| US 8,350,090 | Processes for preparing cyclopentenones and cyclopentenones for the synthesis of benzindene prostaglandins In force · From the USPTO record | In force | From the USPTO record | |
| US 8,658,837 | Intermediates for the synthesis of benzindene prostaglandins and preparations thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 8,524,939 | Intermediates for the synthesis of benzindene prostaglandins and preparations thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 9,464,028 | Processes and intermediates for the preparations of isomer free prostaglandins In force · From the USPTO record | In force | From the USPTO record | |
| US 9,540,311 | Processes and intermediates for the preparations of isomer free prostaglandins In force · From the USPTO record | In force | From the USPTO record | |
| US 9,828,356 | Processes and intermediates for the preparations of isomer free prostaglandis In force · From the USPTO record | In force | From the USPTO record | |
| US 9,890,135 | Processes and intermediates for the preparations of isomer free prostaglandins In force · From the USPTO record | In force | From the USPTO record | |
| US 9,994,543 | Processes and intermediates for the preparations of isomer free prostaglandins In force · From the USPTO record | In force | From the USPTO record | |
| US 10,822,321 | Processes and intermediates for the preparations of isomer free prostaglandins In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 28: 4 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending · 2 no status recorded